Atopic Dermatitis in Skin of Color

  • Zamambo N. C. Mkhize
  • Ncoza C. DlovaEmail author


Atopic dermatitis (AD) is a common inflammatory skin disease which occurs worldwide. It is a chronic relapsing eczematous skin disorder associated with xerosis and pruritus. AD is widespread in industrialized countries with an overall prevalence of 10–20% among school children from the USA and parts of Europe. The countries in South Europe and the African continent show lower prevalence; however, it is a growing clinical problem in sub-Saharan Africa. In West Africa and other parts of the continent, the incidence of AD is considered to involve around 5% of the population, and this rate is still rising. Atopic dermatitis can occur at any age but usually develops in childhood. Its acute phase occurs during infancy and has a predilection for the face and extensors. As the children grow older, the skin lesions become chronic and lichenified, usually involving the flexural areas. There is often an association of AD with a personal or family history of atopy, e.g., asthma, allergic conjunctivitis, and allergic rhinitis.


  1. 1.
    Silverberg JI, Hanifin J, Simpson EL. Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol. 2013;133:1752–9.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Shaw TE, Currie GP. Eczema prevalence in the United States. J Invest Dermatol. 2011;131:67–73.CrossRefPubMedGoogle Scholar
  3. 3.
    Chaumont A, Voisin C, Sardella A, et al. Interactions between domestic water hardness, infant swimming and atopy in the development of childhood eczema. Environ Res. 2012;116:52–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Silverberg JI, Horowitz KB, Kleiman E, et al. Association between varicella zoster virus infection and atopic dermatitis in early and late childhood. J Allergy Clin Immunol. 2010;126:300–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Silverberg JI, Simpson EL. Association between obesity and eczema prevalence, severity and poorer health in US adolescents. Dermatitis. 2014;25:172–81.CrossRefPubMedGoogle Scholar
  6. 6.
    Zhang A, Silverberg JI. Association of atopic dermatitis with being overweight and obese; a systematic review and metaanalysis. J Am Acad Dermatol. 2015;72:606–16.CrossRefPubMedGoogle Scholar
  7. 7.
    Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134:818–23.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Subbaraman R, Shitole S, Shitole T, et al. The social ecology of water in a Mumbai slum: failures in water quality, quantity and reliability. BMC Public Health. 2013;13:173.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Jungersted JM, Hogh JK, Hellgren LI, et al. Ethnicity and stratum corneum ceramides. Br J Dermatol. 2010;163:1169–73.CrossRefPubMedGoogle Scholar
  10. 10.
    Wesley NO, Maibach HI. Racial (ethnic) differences in skin properties; the objective data. Am J Clin Dermatol. 2003;4:843–60.CrossRefPubMedGoogle Scholar
  11. 11.
    Proksch E, Folster-Holst R, Bräutigam M, et al. Role of epidermal barrier in atopic dermatitis. J Dtsch Dermatol Ges. 2009;7:899–910.PubMedGoogle Scholar
  12. 12.
    Vachiramon V, They HL, Thompson AE, et al. Atopic dermatitis in African American children: addressing unmet needs of a common disease. Pediatr Dermatol. 2012;29:395–402.CrossRefPubMedGoogle Scholar
  13. 13.
    Silverberg JI, Simpson EL. Associations of childhood eczema severity: a US population-based study. Dermatitis. 2014;25:107–14.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Wilson D, Berardesca E, Maibach HI. In vivo transepidermal water loss: differences between black and white skin. Br J Dermatol. 1988;119:647–52.CrossRefPubMedGoogle Scholar
  15. 15.
    Kompaore F, Marty JP, Dupont C. In vivo evaluation of the stratum corner barrier function in blacks, Caucasians and Asians with two non-invasive methods. Skin Pharmacol. 1993;6:200–7.CrossRefPubMedGoogle Scholar
  16. 16.
    McDaniel MK, Walfogel J. Racial and ethnic differences in the management of childhood asthma in the United States. J Asthma. 2012;49:785–91.CrossRefPubMedGoogle Scholar
  17. 17.
    Kezic S, Kemperman PM, Koster ES, et al. Loss-of-function stations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol. 2008;128:2117–9.CrossRefPubMedGoogle Scholar
  18. 18.
    O’Regan GM, Sandilands A, McLean WH, et al. Filaggrin in atopic dermatitis. J Allergy Clin Immunol. 2009;124(suppl 2):R2–6.Google Scholar
  19. 19.
    Weidinger S, O’Sullivan M, Illig T, et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol. 2008;121:1203–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Margolis DJ, Apter AJ, Gupta J, et al. The persistence of atopic dermatitis and filaggrin in a US longitudinal cohort. J Allergy Clin Immunol. 2012;130:912–7.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Margolis DJ, Gupta J, Apter AJ, et al. Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects. J Allergy Clin Immunol. 2014;133:784–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Polcari I, Becker L, Stein SL. Filaggrin gene mutations in African Americans with both ichthyosis vulgaris and atopic dermatitis. Pediatr Dermatol. 2014;31:489–92.CrossRefPubMedGoogle Scholar
  23. 23.
    Nnoruka EN. Current epidemiology of atopic dermatitis in south-eastern Nigeria. Int J Dermatol. 2002;43:739–44.CrossRefGoogle Scholar
  24. 24.
    Echenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: Section 1. J Am Acad Dermatol. 2014;70:338–51.CrossRefGoogle Scholar
  25. 25.
    Sudbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: Section 3. J Am Acad Dermatol. 2014;71:327–49.CrossRefGoogle Scholar
  26. 26.
    Garritsen FM, Brouwer MW, Limpens J, et al. Photo(chemo)therapy in the management of atopic dermatitis. Br J Dermatol. 2014;170:501–13.CrossRefPubMedGoogle Scholar
  27. 27.
    Roekevisch E, Spuls PI, Kuester D, et al. Efficacy and safety of systemic treatments for moderate to severe atopic dermatitis. J Allergy Clin Immunol. 2014;133:429–38.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Dermatology, Edendale Hospital Pietermaritzburg, Nelson R Mandela School of MedicineUniversity of KwaZulu-NatalDurbanSouth Africa
  2. 2.Department of Dermatology, Nelson R Mandela School of MedicineUniversity of KwaZulu-NatalDurbanSouth Africa

Personalised recommendations